Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments.
Saved in:
| Title: | Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments. |
|---|---|
| Authors: | Akazawa D; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Ohashi H; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Hishiki T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Morita T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Iwanami S; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan., Kim KS; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Department of Science System Simulation, Pukyong National University, Busan, South Korea.; Department of Mathematics, Pusan National University, Busan, South Korea., Jeong YD; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Department of Mathematics, Pusan National University, Busan, South Korea., Park ES; Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan., Kataoka M; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan., Shionoya K; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.; Department of Applied Biological Science, Tokyo University of Science, Noda, Japan., Mifune J; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Tsuchimoto K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Ojima S; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Azam AH; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Nakajima S; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan., Park H; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan., Yoshikawa T; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan., Shimojima M; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan., Kiga K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Iwami S; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Institute of Mathematics for Industry, Kyushu University, Fukuoka, Japan.; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.; Interdisciplinary Theoretical and Mathematical Sciences Program, RIKEN, Saitama, Japan.; NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.; Science Groove, Inc, Fukuoka, Japan.; MIRAI, Japan Science and Technology Agency, Saitama, Japan., Maeda K; Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan., Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan., Ebihara H; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan., Takahashi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Watashi K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.; Interdisciplinary Biology Laboratory, Graduate School of Science, Nagoya University, Nagoya, Japan.; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.; Department of Applied Biological Science, Tokyo University of Science, Noda, Japan.; MIRAI, Japan Science and Technology Agency, Saitama, Japan. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2023 Aug 31; Vol. 228 (5), pp. 591-603. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
